Thyroid dysfunction in infants with severe intestinal insufficiency: a case series

Gabriela Ibrahim Martins de Castro1, Mário Cícero Falcão1, Juliana Zoboli Del Bigio1

  • 1Universidade de São Paulo, São Paulo, SP, Brazil.

Insights

Infants with severe intestinal dysfunction may develop hypothyroidism due to iodine deficiency from prolonged parenteral nutrition. This highlights a critical need for iodine monitoring and supplementation in neonatal intensive care.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Nutritional Science

Background:

  • Severe intestinal dysfunction in infants necessitates prolonged parenteral nutrition.
  • Thyroid function is crucial for infant development and metabolism.
  • Iodine is an essential component for thyroid hormone synthesis.

Observation:

  • A retrospective study identified seven infants with severe intestinal insufficiency.
  • Four out of seven infants (57.1%) developed thyroid dysfunction.
  • Thyroid dysfunction was linked to prolonged parenteral nutrition without iodine supplementation.

Findings:

  • The primary cause of hypothyroidism in these cases was identified as iodine deficiency.
  • Levothyroxine replacement therapy was administered to affected infants.
  • The study highlights a gap in parenteral nutrition protocols regarding iodine content.

Implications:

  • Neonatal intensive care units should assess and address iodine status in infants receiving long-term parenteral nutrition.
  • Supplementation of iodine in parenteral nutrition solutions is crucial to prevent hypothyroidism.
  • Early detection and management of thyroid dysfunction are vital for improved outcomes in infants with intestinal failure.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
381
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
4.1K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
212
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
246
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
265
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
507